Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · Real-Time Price · USD
0.665
-0.026 (-3.70%)
At close: Nov 22, 2024, 4:00 PM
0.698
+0.033 (5.01%)
After-hours: Nov 22, 2024, 4:54 PM EST
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $3.85 million as of November 22, 2024. Its market cap has decreased by -67.62% in one year.
Market Cap
3.85M
Enterprise Value
6.28M
1-Year Change
-67.62%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since February 11, 2014, Hepion Pharmaceuticals's market cap has decreased from $34.20M to $3.85M, a decrease of -88.73%. That is a compound annual growth rate of -18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 4.80M | -65.96% |
| Dec 29, 2023 | 14.10M | -38.43% |
| Dec 30, 2022 | 22.90M | -73.65% |
| Dec 31, 2021 | 86.90M | 338.89% |
| Dec 31, 2020 | 19.80M | 7.03% |
| Dec 31, 2019 | 18.50M | 302.17% |
| Dec 31, 2018 | 4.60M | -83.69% |
| Dec 29, 2017 | 28.20M | -60.78% |
| Dec 30, 2016 | 71.90M | 71.19% |
| Dec 31, 2015 | 42.00M | -14.98% |
| Dec 31, 2014 | 49.40M | 44.44% |
| Feb 11, 2014 | 34.20M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Predictive Oncology | 4.35M |
| Biofrontera | 4.32M |
| Silo Pharma | 4.24M |
| Pasithea Therapeutics | 4.04M |
| Aptorum Group | 4.03M |
| Genprex | 3.96M |
| Sonoma Pharmaceuticals | 3.80M |
| Genetic Technologies | 3.78M |